Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters

被引:35
作者
Fragaki, K [1 ]
Suffia, I [1 ]
Ferrua, B [1 ]
Rousseau, D [1 ]
Le Fichoux, Y [1 ]
Kubar, J [1 ]
机构
[1] Fac Med, Parasitol Lab, IFR 50, Grp Rech Immunopathol Leishmaniose EA 2676, F-06107 Nice 2, France
关键词
vaccine; parasitemia; visceral leishmaniasis;
D O I
10.1016/S0264-410X(00)00398-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We tested in outbred golden hamsters the protective potential of highly immunogenic Leishmania infantum protein papLe22 which we recently identified. Immunisation was performed using papLe22 cDNA, administered as a single intramuscular injection. The level of antibodies directed against total leishmanial antigens was significantly decreased in the vaccinated hamsters as compared with the controls, indicating that the administration of papLe22 cDNA downregulated the Th2 type response and suggesting that the immune response was reoriented toward the cell-mediated type. The presence of the parasite kDNA in the peripheral blood was systematically detected as early as 3 weeks post infection in all mock-vaccinated hamsters. By contrast, in the vaccinated animals the occurrence of the episodes of Leishmania circulation was reduced by 50%. The immunisation presenting efficacy in this highly susceptible species which develop VL similar in gravity to human and canine disease should prove also efficient in naturally infected hosts. The marked decrease of the frequency of parasite circulation induced by papLe22 cDNA immunisation appears therefore important and potentially able to reduce transmission and thus to control the spread of the disease. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1701 / 1709
页数:9
相关论文
共 39 条
[1]   DNA vaccines: Technology and application as anti-parasite and anti-microbial agents [J].
Alarcon, JB ;
Waine, GW ;
McManus, DP .
ADVANCES IN PARASITOLOGY, VOL 42, 1999, 42 :343-410
[2]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[3]   Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production [J].
Asakura, Y ;
Liu, LJ ;
Shono, N ;
Hinkula, J ;
Kjerrström, A ;
Aoki, I ;
Okuda, K ;
Wahren, B ;
Fukushima, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (01) :130-139
[4]   NEW PERSPECTIVES ON A SUBCLINICAL FORM OF VISCERAL LEISHMANIASIS [J].
BADARO, R ;
JONES, TC ;
CARVALHO, EM ;
SAMPAIO, D ;
REED, SG ;
BARRAL, A ;
TEIXEIRA, R ;
JOHNSON, WD .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (06) :1003-1011
[5]  
Bories C, 1998, ANN TROP MED PARASIT, V92, P685, DOI 10.1080/00034989859140
[6]  
Bradley D.J., 1987, P551
[7]   Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis [J].
De Luca, PM ;
Mayrink, W ;
Alves, CR ;
Coutinho, SG ;
Oliveira, MP ;
Bertho, AL ;
Toledo, VP ;
Costa, CA ;
Genaro, O ;
Mendonça, SCF .
VACCINE, 1999, 17 (9-10) :1179-1185
[8]   Global control and leishmania HIV co-infection [J].
Desjeux, P .
CLINICS IN DERMATOLOGY, 1999, 17 (03) :317-325
[9]   Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG [J].
Dube, A ;
Sharma, P ;
Srivastava, JK ;
Misra, A ;
Naik, S ;
Katiyar, JC .
PARASITOLOGY, 1998, 116 :219-221
[10]   Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major [J].
Gurunathan, S ;
Sacks, DL ;
Brown, DR ;
Reiner, SL ;
Charest, H ;
Glaichenhaus, N ;
Seder, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1137-1147